fda tirzepatide update Lilly's new drug Mounjaro (tirzepatide ) wins US approval FDA confirms tirzepatide shortage is

L-carnitine speelt een cruciale rol bij de energieproductie

Retatrutide clinical trials and preliminary results Eli Lilly, the manufacturer of Retatrutide, completed their Phase II trials and released results in June 2023

Additionally, Epithalon may assist immune function, potentially enhancing resistance to infection, especially during periods of increased susceptibility

(NIDDK) I also see a second misconception: that success on these medications is purely about eating less. In reality, the reason many patients do better with GLP-1-based treatment is that these medications can change the biology driving overeating, poor fullness signaling, and dysregulated blood sugar

Using probiotic supplements or consuming probiotic-rich foods (such as yoghurt or kefir) may be a good idea

For obstructive sleep apnea in obese adults, coverage is required in all states (since December 2024)